Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/2012
10/04/2012US20120252830 Substituted Aminobutyric Derivatives as Neprilysin Inhibitors
10/04/2012US20120252829 Tivozanib and capecitabine combination therapy
10/04/2012US20120252827 Combination of therapy comprising zd6474 and a taxane
10/04/2012US20120252826 Combination Therapy
10/04/2012US20120252822 Inhibitors of bruton's tyrosine kinase
10/04/2012US20120252821 Inhibitors of bruton's tyrosine kinase
10/04/2012US20120252818 Heat shock protein binding compounds, compositions, and methods for making and using same
10/04/2012US20120252816 Use of phosphodiesterase inhibitors for treating multidrug resistance
10/04/2012US20120252815 Inhibitors of sphingosine kinase
10/04/2012US20120252811 Combinations of therapeutic agents for treating cancer
10/04/2012US20120252806 Inhibitors of akt activity
10/04/2012US20120252798 Indole compounds as an inhibitor of cellular necrosis
10/04/2012US20120252797 Isoxazole Compounds As Inhibitors Of Heat Shock Proteins
10/04/2012US20120252792 Methods and compositions for modulating rho-mediated gene transcription
10/04/2012US20120252790 Amino-Derivatives As Novel Inhibitors Of Histone Deacetylase
10/04/2012US20120252789 Inhibitors of sphingosine kinase
10/04/2012US20120252785 Staurosporine derivatives as inhibitors of flt3 receptor tyrosine kinase activity
10/04/2012US20120252781 Benzodiazepine Bromodomain Inhibitor
10/04/2012US20120252778 Pyrazolo pyrimidine derivatives
10/04/2012US20120252777 Thiazolopyrimidine compounds
10/04/2012US20120252773 Method and composition for inhibiting cell proliferation and angiogenesis
10/04/2012US20120252768 Composition containing protopanaxatriol and protopanaxadiol
10/04/2012US20120252763 Novel group of stat3 pathway inhibitors and cancer stem cell pathway inhibitors
10/04/2012US20120252762 Anti-cancer agent
10/04/2012US20120252759 Thiazole derivatives for the treatment of diseases such as cancer
10/04/2012US20120252753 Therapeutic target for pancreatic cancer cells
10/04/2012US20120252749 Methods of Treating Cancer with Glut Inhibitors
10/04/2012US20120252748 Methods and compositions for determining the responsiveness of cancer therapeutics
10/04/2012US20120252747 Macrocyclic compounds and methods of making and using the same
10/04/2012US20120252745 Novobiocin analogues having modified sugar moieties
10/04/2012US20120252742 Human Single-Chain T Cell Receptors
10/04/2012US20120252740 Hdac inhibitors and therapeutic methods of using same
10/04/2012US20120252739 Tubulin Inhibitors
10/04/2012US20120252738 Tubulin Inhibitors
10/04/2012US20120252737 Methods for Diagnosing and Treating Cancer
10/04/2012US20120252736 Methods involving pdgfrbeta inhibitors
10/04/2012US20120252735 Treatment of skin conditions by dickkopf1 (dkk1)
10/04/2012US20120252732 Albumin fusion proteins
10/04/2012US20120252723 Regulating the Amino Acid Pool Used for the Acute-Phase Protein Synthesis
10/04/2012US20120252722 Metal-binding therapeutic peptides
10/04/2012US20120252720 Compositions for treatment of ear disorders and methods of use thereof
10/04/2012US20120252097 Therapeutic Agents Comprising Pro-Apoptotic Proteins
10/04/2012US20120251644 Anticancer composition
10/04/2012US20120251630 Remission therapy of cancer with isoflavonoids
10/04/2012US20120251629 Methods of treatment and screening assays for hif-1alpha regulation
10/04/2012US20120251628 Compositions and methods for treatment of cancer
10/04/2012US20120251620 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
10/04/2012US20120251619 MicroRNA-29a,b,c as a Tumor Suppressor and Sensitizing Agent for Chemotherapy
10/04/2012US20120251617 Bi-functional shrna targeting stathmin 1 and uses thereof
10/04/2012US20120251616 Tocopherols, Tocotrienols, Other Chroman and Side Chain Derivatives and Uses Thereof
10/04/2012US20120251594 Delivery of Submicrometer and Nanometer Aerosols to the Lungs Using Hygroscopic Excipients or Dual Stream Nasal Delivery
10/04/2012US20120251580 Methods of use for a natural thomsen-friedenreich disaccharide compound
10/04/2012US20120251579 Compositions for generating an antigen specific immune response
10/04/2012US20120251563 Modulation of immune response by non-peptide binding stress response polypeptides
10/04/2012US20120251562 Inhibitors of the PP1/GADD34 Complex for the Treatment of a Condition Requiring an Immunosuppressive Activity
10/04/2012US20120251561 Administration of dendritic cells partially matured in vitro for the treatment of tumors
10/04/2012US20120251560 Conjugated lipomers and uses thereof
10/04/2012US20120251559 Treatment of B-Cell Cancers With Anti-CD70 Antibody-Drug Conjugates
10/04/2012US20120251558 Antibody-drug conjugates
10/04/2012US20120251557 GalNAc-SPECIFIC BINDING MOLECULES AND USES THEREOF
10/04/2012US20120251556 Combination Immunotherapy for the Treatment of Cancer
10/04/2012US20120251555 Antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen and uses thereof
10/04/2012US20120251551 Substituted (Heteroarylmethyl)thiohydantoins
10/04/2012US20120251550 Crystalline anti-hTNFalpha antibodies
10/04/2012US20120251545 Therapeutic Combinations Of Hydroxybenzamide Derivatives As Inhibitors Of HSP90
10/04/2012US20120251543 Methods and compositions for modulating apoptosis
10/04/2012US20120251540 Stabilized single domain antibodies
10/04/2012US20120251538 Use of fgfr1 extra cellular domain proteins to treat cancers characterized by ligand-dependent activating mutations in fgfr2
10/04/2012US20120251537 Compositions and methods for the treatment of infections and tumors
10/04/2012US20120251535 Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody
10/04/2012US20120251534 Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody
10/04/2012US20120251532 Anti-alpha v beta 6 antibodies
10/04/2012US20120251530 Combination therapy of her expressing tumors
10/04/2012US20120251529 Anti-cea antibodies
10/04/2012US20120251528 Non-Human Mammal Model Of Human Hematopoietic Cancer
10/04/2012US20120251527 Podocyte specific assays and uses thereof
10/04/2012US20120251525 Method of utilizing azelaic acid esters to modulate communications mediated by biological molecules
10/04/2012US20120251521 Technical field and industrial applicability of the invention
10/04/2012US20120251516 Pharmaceutical composition for treating cancer comprising trypsinogen and/or chymotrypsinogen and an active agent selected from a selenium compound, a vanilloid compound and a cytoplasmic glycolysis reduction agent
10/04/2012US20120251509 Cell-based anti-cancer compositions and methods of making and using the same
10/04/2012US20120251499 Method for diagnosis/prognosis of cancers using an epigenetic marker consisting of a specific single cpg site in ttp promoter and treatment of cancers by regulating its epigenetic status
10/04/2012US20120251496 Ezatiostat for treating multiple myeloma
10/04/2012US20120251495 Pterin based therapies for inflammatory conditions
10/04/2012US20120251490 Compositions And Methods For Immunotherapy
10/04/2012US20120251489 Adult stem cell derived conditioned medium and/or adult stem cells for use in the therapeutic treatment of a tumor disease
10/04/2012US20120251486 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same
10/04/2012US20120251463 Nicotinamide Riboside Kinase Compositions and Methods for Using the Same
10/04/2012US20120251454 Human Anti-IL-23 Antibodies, Compositions, Methods and Uses
10/04/2012US20120251453 Methods and Compositions Related to Annexin 1-Binding Compounds
10/04/2012US20120251449 Aldh: a compound for cancer stem cell imaging
10/04/2012US20120251444 Treatment of liver disorders by administration of rap conjugates
10/04/2012US20120251442 Methods for Treatment of Tumors by Direct Administration of a Radioisotope
10/04/2012US20120251441 Adjuvant immunotherapy for the preventive, curative or palliative treatment of chronic systemic diseases such as cancer, of clinical manifestations associated with diseases like cachexia and correction of adverse effects of drugs such as immunosuppression, neutropenia and lymphopenia, comprising the association or combination of a biological response modifier specially selected and other substances with antineoplastic action and/or other treatments
10/04/2012CA2844699A1 Combinations of akt inhibitor compounds and abiraterone, and methods of use
10/04/2012CA2837122A1 Methods and compositions for enhancing the uptake of therapeutic agents by target cells
10/04/2012CA2831937A1 Combinations of akt inhibitor compounds and erlotinib, and methods of use
10/04/2012CA2831935A1 Combinations of akt inhibitor compounds and chemotherapeutic agents, and methods of use
10/04/2012CA2831932A1 Combinations of akt and mek inhibitor compounds, and methods of use
10/04/2012CA2831929A1 Pyrazolo pyrimidine derivatives
10/04/2012CA2831915A1 Modulation of signal transducer and activator of transcription 3 (stat3) expression
1 ... 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 ... 2211